Profilo
Gregory B.
Holmes joined SFBC International, Inc. as Executive Vice President-Clinical Operations in February 1999.
He is Executive Vice President-Clinical Operations for Pharmanet Development Group, Inc. From January 1997 to February 1999, he was President of Clinical Research for Phoenix International Life Sciences, Inc.
Precedenti posizioni note di Gregory B. Holmes
| Società | Posizione | Fine |
|---|---|---|
Phoenix International Life Sciences, Inc.
 Phoenix International Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sotera Health Co., Phoenix International Life Sciences, Inc. is a Canadian company that provides bioanalytical research and clinical testing services. The company is based in Saint-Laurent, Canada. Phoenix International Life Sciences was acquired by Nordion (Canada), Inc., part of Sotera Health Co. from July 30, 2018 on May 22, 2000 for $236.74 million. | Corporate Officer/Principal | 01/02/1999 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Phoenix International Life Sciences, Inc.
Phoenix International Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sotera Health Co., Phoenix International Life Sciences, Inc. is a Canadian company that provides bioanalytical research and clinical testing services. The company is based in Saint-Laurent, Canada. Phoenix International Life Sciences was acquired by Nordion (Canada), Inc., part of Sotera Health Co. from July 30, 2018 on May 22, 2000 for $236.74 million. | Commercial Services |
- Borsa valori
- Insiders
- Gregory B. Holmes
